Does CILTACABTAGENE AUTOLEUCEL Cause Adverse event? 143 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Adverse event have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 3.8% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
143
Reports of Adverse event with CILTACABTAGENE AUTOLEUCEL
3.8%
of all CILTACABTAGENE AUTOLEUCEL reports
6
Deaths
49
Hospitalizations
How Dangerous Is Adverse event From CILTACABTAGENE AUTOLEUCEL?
Of the 143 reports, 6 (4.2%) resulted in death, 49 (34.3%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Adverse event Listed in the Official Label?
Yes, Adverse event is listed as a known adverse reaction in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
Cranial nerve paralysis (115)
What Other Drugs Cause Adverse event?
ABATACEPT (4,028)
APIXABAN (3,871)
ETANERCEPT (3,096)
LENALIDOMIDE (2,426)
INFLIXIMAB (2,269)
ADALIMUMAB (2,121)
METHOTREXATE (1,846)
LEFLUNOMIDE (1,476)
RIVAROXABAN (1,465)
ALENDRONATE (1,462)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Adverse event Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE